Mein Warenkorb

Human PAR1 Full Length Protein (VLP)

User Reviews
Product Number/Spec
Price
Menge
PA1-H52P6-20ug
$620.00
PA1-H52P6-100ug
$1235.00
PA1-H52P6-500ug (250ug X 2)
$4305.00
ETA of in-stock products:2 business days
Gesamtanzahl Product Amount$ 0

Product Details

  • Application

    1. Immunization
    2. Cell based assay (FACS or functional assay)
    3. Screening (ELISA)
  • Synonyms

    F2R, coagulation factor II thrombin receptor, CF2R, HTR, PAR-1, PAR1, TR

  • Source

    Human PAR1 Full Length Protein-VLP (PA1-H52P6) is expressed from human 293 cells (HEK293). It contains AA Ser 42 - Thr 425 (Accession # P25116-1).

    Predicted N-terminus: Asp

  • Molecular Characterization

    *The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

    2. Synthesis Process

      Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Formulation

    The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

    Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 12 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Kunden haben auch angesehen

Data Display

  • Bioactivity-ELISA

     PAR1 ELISA

    Immobilized Human PAR1 Full Length Protein-VLP (Cat. No. PA1-H52P6) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-Human PAR1 antibody, Mouse IgG1 with a linear range of 0.1-1.3 μg/mL (QC tested).

    Protocol
  • Identity-DLS

     PAR1 DLS

    The mean peak Radius of VLP is 50-70 nm with more than 95% intensity as determined by dynamic light scattering (DLS).

User Reviews
Publish Comment

Background Introduction

Protease-Activated Receptor 1, the primary thrombin receptor on human platelets, mediating platelet activation and shape change. It is a validated target for preventing arterial thrombosis (vorapaxar). PAR1 also couples thrombin signaling to cancer cell invasion, angiogenesis, and fibroblast activation in the tumor stroma.

Frontier Progress

 
Drug Development Progress
  • English Name:

    Protease-activated receptor-1

  • Category:

  • Listed Drugs Count:

    0 Details

  • Clinical Drugs Count:

    3 Details

  • Highest R&D Stage:

    Phase 1 Clinical

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Kunden haben auch angesehen
  • Data Display
  • User Reviews
  • Hintergrund
Kontaktieren Sie uns